Park West Asset Management LLC Takes Position in Oscar Health, Inc. (NYSE:OSCR)

Park West Asset Management LLC acquired a new position in Oscar Health, Inc. (NYSE:OSCRFree Report) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 674,067 shares of the company’s stock, valued at approximately $6,168,000.

Several other institutional investors also recently bought and sold shares of OSCR. Vanguard Group Inc. raised its holdings in shares of Oscar Health by 18.6% in the 3rd quarter. Vanguard Group Inc. now owns 14,127,934 shares of the company’s stock valued at $78,693,000 after purchasing an additional 2,211,743 shares in the last quarter. Formation8 GP LLC bought a new position in Oscar Health in the fourth quarter worth approximately $47,480,000. Dimensional Fund Advisors LP lifted its holdings in Oscar Health by 14.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,162,935 shares of the company’s stock worth $28,942,000 after buying an additional 392,837 shares during the period. Gilder Gagnon Howe & Co. LLC boosted its position in Oscar Health by 21.0% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 2,830,947 shares of the company’s stock valued at $25,903,000 after acquiring an additional 491,861 shares in the last quarter. Finally, Ancient Art L.P. increased its holdings in shares of Oscar Health by 91.9% in the 3rd quarter. Ancient Art L.P. now owns 2,793,141 shares of the company’s stock valued at $15,558,000 after acquiring an additional 1,337,987 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Oscar Health

In other news, COO Steven Wolin sold 18,607 shares of the firm’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $362,092.22. Following the completion of the transaction, the chief operating officer now directly owns 65,316 shares in the company, valued at $1,271,049.36. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Oscar Health news, EVP Alessandrea C. Quane sold 25,550 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $497,203.00. Following the sale, the executive vice president now directly owns 237,347 shares of the company’s stock, valued at $4,618,772.62. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Steven Wolin sold 18,607 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $362,092.22. Following the sale, the chief operating officer now directly owns 65,316 shares in the company, valued at $1,271,049.36. The disclosure for this sale can be found here. Insiders have sold a total of 81,655 shares of company stock valued at $1,589,006 in the last ninety days. Company insiders own 25.11% of the company’s stock.

Oscar Health Stock Down 0.3 %

Shares of OSCR traded down $0.06 during mid-day trading on Thursday, hitting $19.00. 2,865,799 shares of the company traded hands, compared to its average volume of 3,344,458. The business has a 50 day moving average of $18.84 and a 200 day moving average of $14.57. The company has a market capitalization of $4.51 billion, a PE ratio of -47.50 and a beta of 1.68. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.29. Oscar Health, Inc. has a 1-year low of $4.72 and a 1-year high of $23.44.

Oscar Health (NYSE:OSCRGet Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.34. Oscar Health had a negative net margin of 0.82% and a negative return on equity of 5.77%. The business had revenue of $2.14 billion for the quarter, compared to analyst estimates of $1.99 billion. During the same quarter in the prior year, the business posted ($0.18) EPS. Oscar Health’s revenue for the quarter was up 45.8% compared to the same quarter last year. Equities research analysts anticipate that Oscar Health, Inc. will post -0.04 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Baird R W upgraded Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Raymond James assumed coverage on shares of Oscar Health in a research report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price target for the company. TheStreet upgraded shares of Oscar Health from a “d” rating to a “c-” rating in a report on Wednesday, February 21st. Bank of America reiterated a “neutral” rating and set a $21.00 price objective (down previously from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Finally, Wells Fargo & Company raised their target price on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday. Three research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $19.00.

Check Out Our Latest Stock Analysis on OSCR

Oscar Health Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Featured Stories

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCRFree Report).

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.